Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
European Journal of Medicinal Chemistry|December 9, 2014
New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2Dinesh Manvar, Sveva Pelliccia, Giuseppe La Regina, et al.
Journal of Medicinal Chemistry|September 19, 2017
Computer-Aided Identification and Lead Optimization of Dual Murine Double Minute 2 and 4 Binders: Structure-Activity Relationship Studies and Pharmacological ActivityMariateresa Giustiniano, Simona Daniele, Sveva Pelliccia, et al.
European Journal of Medicinal Chemistry|May 7, 2018
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitorsGiuseppe La Regina, Ruoli Bai, Antonio Coluccia, et al.
Circulation Research|January 13, 2023
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 InfectionRoberto Carnevale, Vittoria Cammisotto, Simona Bartimoccia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 19, 2017
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptorsAdriano Mollica, Sveva Pelliccia, Valeria Famiglini, et al.
European Journal of Pharmacology|February 13, 2021
CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiformeSimona Daniele, Valeria La Pietra, Rebecca Piccarducci, et al.
Journal of Medicinal Chemistry|August 11, 2025
Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal CancerDomiziana Masci, Lele Ling, Lian Yang, et al.
European Journal of Medicinal Chemistry|October 15, 2010
Synthesis and biological evaluation of new N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligandsRomano Silvestri, Alessia Ligresti, Giuseppe La Regina, et al.
Pageof 16